# Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy Subjects

> **NCT00456417** · PHASE1 · COMPLETED · sponsor: **Institute for Neurodegenerative Disorders** · enrollment: 30 (estimated)

## Conditions studied

- Alzheimers Disease

## Interventions

- **DRUG:** 123-I MNI-187 Injection and Imaging Procedures

## Key facts

- **NCT ID:** NCT00456417
- **Lead sponsor:** Institute for Neurodegenerative Disorders
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2019-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00456417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00456417, "Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy Subjects". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00456417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*